Follicle stimulating hormone glyco-optimised - Glycotope

Alternative Names: Follicle stimulating hormone - Glycotope; FSH-GEX; Glyco-optimized follicle-stimulating hormone - Glycotope; GT-GP-2.4 GEX

Latest Information Update: 24 Sep 2021

Price : $50 ^*

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Glycotope
Class Follicle stimulating hormones; Infertility therapies; Pituitary gonadotropins
Mechanism of Action Ovarian follicle stimulants

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

24 Sep 2021 Discontinued - Phase-III for Female infertility (SC)
13 Jul 2016 Phase-III clinical trials in Female infertility (SC) before July 2016
04 Sep 2015 Clinical development of follicle stimulating hormone glyco-optimized is ongoing

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com